[HTML][HTML] Targeting the root cause of mucopolysaccharidosis IIIA with a new scAAV9 gene replacement vector

TA Bobo, PN Samowitz, MI Robinson, H Fu - Molecular Therapy-Methods & …, 2020 - cell.com
No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA
patients. Targeting the root cause, we developed a new self-complementary adeno …

[HTML][HTML] Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector

TA Bobo, PN Samowitz, MI Robinson, H Fu - Molecular Therapy-Methods & …, 2020 - Elsevier
No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA
patients. Targeting the root cause, we developed a new self-complementary adeno …

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector

TA Bobo, PN Samowitz… - … therapy. Methods & …, 2020 - pubmed.ncbi.nlm.nih.gov
No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA
patients. Targeting the root cause, we developed a new self-complementary adeno …

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector

TA Bobo, PN Samowitz… - … Methods and Clinical …, 2020 - ohiostate.elsevierpure.com
No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA
patients. Targeting the root cause, we developed a new self-complementary adeno …

[引用][C] Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector

TA Bobo, PN Samowitz, MI Robinson… - … Therapy-Methods & …, 2020 - cir.nii.ac.jp
Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene
Replacement Vector | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

[HTML][HTML] Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector

TA Bobo, PN Samowitz, MI Robinson… - … Therapy. Methods & …, 2020 - ncbi.nlm.nih.gov
No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA
patients. Targeting the root cause, we developed a new self-complementary adeno …

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector.

TA Bobo, PN Samowitz, MI Robinson… - … therapy. Methods & …, 2020 - europepmc.org
No treatment is available to address the unmet needs of mucopolysaccharidosis (MPS) IIIA
patients. Targeting the root cause, we developed a new self-complementary adeno …